NAICS category

Research and Development in Biotechnology

NAICS 541711

FY2026 ended Sep 30 · data still posting · data as of 2026-11-01†

† DoD contract data posts to USAspending about 90 days after award.

Part of Professional, Scientific, and Technical Services →

$1.3B
Federal awards
FY2026 · data still posting
16
Recipients
NAICS 541711
Code

NAICS code 541711 (Research and Development in Biotechnology) accounted for $1.3B in federal contracts in FY2026, led by the Department of Energy, across 16 recipients. Its largest recipient on record was Alliance for Energy Innovation, LLC, with 77%. FY2026 ended Sep 30 and its data is still posting. Computed

Obligations by year

Computed
$2.9B
FY20
$1.7B
FY21
$988.2M
FY22
$1.9B
FY23
$1.2B
FY24
$895M
FY25
$1.3B
FY26 partial
▼ 69%
FY20 to FY25

Key takeaways

Computed
FY2026 ended Sep 30 · data still posting · data as of 2026-11-01
  • Research and Development in Biotechnology (NAICS 541711) accounted for $1.3B in federal obligations in FY2026, compared with $895M in FY2025.
  • It ranked #65 among industries by federal contract dollars in FY2026 (data still posting).
  • The Department of Energy provided 77% of it.
  • Its largest recipient was Alliance for Energy Innovation, LLC, with 77%.

Top recipients

Computed
Alliance for Energy Innovation, LLC$1B
Regeneron Pharmaceuticals Inc$279.4M
Battelle Memorial Institute$1.7M
University of Alabama at Birmingham$318K

Recipient breakdown available for 98% of obligations shown

Awards

Source

Largest FY2026 awards in this category

Awards coded NAICS 541711 that started in FY2026, by the amount obligated on each so far.

No award on record in this category started in FY2026.

Largest awards in this category

Award of Contract to Manage and Operate the National Renewable Energy Laboratory
awarded 2008$11.3B
Contract HHSO100201600030C
awarded 2016$1.4B
Contract HHSO100201700016C
awarded 2017$973.6M
Drugs and Biologicals
awarded 2011$518.5M
Regeneron Other Transaction Authority (OTA) Award
awarded 2017$278.8M
Contract HHSO100201700012C
awarded 2017$236.3M
Base Period: Program Management Evms
awarded 2012$191.3M
Cerus - Development and Implementation of Pathogen Reduction Technology (PRT)
awarded 2016$185.2M

Total value over each award’s life, largest first.

Related

Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.